We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
CD30-positive Cutaneous Pseudolymphoma Caused by Tocilizumab in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.
- Authors
Akiha Inoue; Yu Sawada; Shun Ohmori; Daisuke Omoto; Sanehito Haruyama; Manabu Yoshioka; Daisuke Nishio; Motonobu Nakamura
- Abstract
The article presents a case study of CD30-positive cutaneous pseudolymphoma caused by tocilizumab, a biological disease-modifying anti-rheumatic drug (DMARD) that targets interleukin 6 (IL-6) receptor, blocking IL-6 signalling, in a 68-year-old woman patient. She was treated with topical patient was treated with topical betamethasone butyrate propionate ointment. The article discusses drug eruptions due to tocilizumab.
- Subjects
TOCILIZUMAB; DRUG side effects; LYMPHOMA diagnosis; BUTYRATES; ANTIRHEUMATIC agents
- Publication
Acta Dermato-Venereologica, 2016, Vol 96, Issue 4, p570
- ISSN
0001-5555
- Publication type
Case Study
- DOI
10.2340/00015555-2309